Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$1.16
-3.3%
$1.22
$0.84
$2.03
$44.23M0.99118,426 shs13,256 shs
CZX
Canada Zinc Metals
C$0.31
+∞
C$0.31
C$0.22
C$0.39
C$51.69MN/A238,645 shs118,500 shs
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$20.86
C$18.60
C$22.79
N/AN/A468,009 shs3.04 million shs
Teradyne, Inc. stock logo
TER
Teradyne
$108.91
+8.2%
$105.25
$81.07
$119.20
$16.66B1.561.88 million shs7.88 million shs
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
+7.21%+7.21%-0.83%+9.17%-25.63%
CZX
Canada Zinc Metals
0.00%0.00%0.00%0.00%0.00%
First Capital Realty Inc. stock logo
FCR
First Capital Realty
0.00%0.00%0.00%0.00%0.00%
Teradyne, Inc. stock logo
TER
Teradyne
+0.85%-1.34%-7.53%-8.41%+6.73%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
2.6485 of 5 stars
3.50.00.00.03.23.31.3
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/AN/AN/A
Teradyne, Inc. stock logo
TER
Teradyne
4.569 of 5 stars
1.15.01.73.43.13.33.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
3.00
Buy$7.00503.45% Upside
CZX
Canada Zinc Metals
N/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/A
Teradyne, Inc. stock logo
TER
Teradyne
2.29
Hold$113.734.42% Upside

Current Analyst Ratings

Latest TER, BOLT, CZX, and FCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2024
Teradyne, Inc. stock logo
TER
Teradyne
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$110.00
4/16/2024
Teradyne, Inc. stock logo
TER
Teradyne
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$130.00
4/11/2024
Teradyne, Inc. stock logo
TER
Teradyne
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$100.00 ➝ $110.00
3/22/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
3/4/2024
Teradyne, Inc. stock logo
TER
Teradyne
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$110.00
2/15/2024
Teradyne, Inc. stock logo
TER
Teradyne
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Neutral$90.00 ➝ $100.00
1/31/2024
Teradyne, Inc. stock logo
TER
Teradyne
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$110.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$7.88M5.61N/AN/A$2.97 per share0.39
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/A
Teradyne, Inc. stock logo
TER
Teradyne
$2.68B6.22$4.21 per share25.87$16.52 per share6.59

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$69.20M-$1.83N/AN/AN/A-878.58%-51.18%-37.81%5/9/2024 (Estimated)
CZX
Canada Zinc Metals
N/AN/A0.00N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/A0.00N/AN/AN/AN/AN/A5/1/2024 (Confirmed)
Teradyne, Inc. stock logo
TER
Teradyne
$448.75M$2.7339.8925.27N/A16.77%19.45%14.05%7/24/2024 (Estimated)

Latest TER, BOLT, CZX, and FCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.29N/A-C$0.29N/AN/AN/A
4/24/2024Q1 2024
Teradyne, Inc. stock logo
TER
Teradyne
$0.33$0.51+$0.18$0.62$566.31 million$599.82 million  
3/21/2024Q4 2023
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$0.47-$0.47N/A-$0.47$1.97 million$2.09 million
2/6/2024Q4 2023
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.31C$0.81+C$0.50C$0.81N/AC$171.18 million
1/30/2024Q4 23
Teradyne, Inc. stock logo
TER
Teradyne
$0.72$0.79+$0.07$0.86$674.99 million$670.60 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
N/AN/AN/AN/AN/A
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/A
Teradyne, Inc. stock logo
TER
Teradyne
$0.480.44%+3.23%17.58%1 Years

Latest TER, BOLT, CZX, and FCR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.074.14%4/29/20244/30/20245/15/2024
3/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.073/27/20243/28/20244/15/2024
2/6/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.072/28/20242/29/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
0.15
5.17
5.17
CZX
Canada Zinc Metals
N/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/A
Teradyne, Inc. stock logo
TER
Teradyne
N/A
3.28
2.81

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
86.70%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
Teradyne, Inc. stock logo
TER
Teradyne
99.77%

Insider Ownership

CompanyInsider Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
28.40%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
Teradyne, Inc. stock logo
TER
Teradyne
0.36%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10038.13 million27.30 millionNot Optionable
CZX
Canada Zinc Metals
147,000166.73 millionN/ANot Optionable
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/ANot Optionable
Teradyne, Inc. stock logo
TER
Teradyne
6,500152.97 million152.42 millionOptionable

TER, BOLT, CZX, and FCR Headlines

SourceHeadline
Top Tech Stocks Moving Higher After EarningsTop Tech Stocks Moving Higher After Earnings
zacks.com - April 25 at 5:36 PM
Teradyne (TER) Q1 Earnings Top Estimates, Revenues Fall Y/YTeradyne (TER) Q1 Earnings Top Estimates, Revenues Fall Y/Y
zacks.com - April 25 at 3:16 PM
Teradyne (TER) Shares Skyrocket, What You Need To KnowTeradyne (TER) Shares Skyrocket, What You Need To Know
finance.yahoo.com - April 25 at 1:20 PM
Teradyne (NASDAQ:TER) Shares Gap Up  on Better-Than-Expected EarningsTeradyne (NASDAQ:TER) Shares Gap Up on Better-Than-Expected Earnings
marketbeat.com - April 25 at 10:49 AM
Teradyne (NASDAQ:TER) Receives "Neutral" Rating from Cantor FitzgeraldTeradyne (NASDAQ:TER) Receives "Neutral" Rating from Cantor Fitzgerald
marketbeat.com - April 25 at 10:25 AM
Why Investors Need to Take Advantage of These 2 Computer and Technology Stocks NowWhy Investors Need to Take Advantage of These 2 Computer and Technology Stocks Now
zacks.com - April 25 at 9:51 AM
Why Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving PremarketWhy Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
msn.com - April 25 at 9:00 AM
Teradyne Inc (TER) Q1 2024 Earnings: Surpasses Analyst Revenue and EPS ForecastsTeradyne Inc (TER) Q1 2024 Earnings: Surpasses Analyst Revenue and EPS Forecasts
finance.yahoo.com - April 25 at 8:18 AM
Handelsbanken Fonder AB Purchases 35,543 Shares of Teradyne, Inc. (NASDAQ:TER)Handelsbanken Fonder AB Purchases 35,543 Shares of Teradyne, Inc. (NASDAQ:TER)
marketbeat.com - April 25 at 6:43 AM
TER Stock Earnings: Teradyne Beats EPS, Beats Revenue for Q1 2024TER Stock Earnings: Teradyne Beats EPS, Beats Revenue for Q1 2024
investorplace.com - April 24 at 11:13 PM
Teradyne (NASDAQ:TER) Issues Quarterly  Earnings ResultsTeradyne (NASDAQ:TER) Issues Quarterly Earnings Results
marketbeat.com - April 24 at 9:08 PM
Teradyne (NASDAQ:TER) Issues Q2 Earnings GuidanceTeradyne (NASDAQ:TER) Issues Q2 Earnings Guidance
marketbeat.com - April 24 at 9:08 PM
Heres What Key Metrics Tell Us About Teradyne (TER) Q1 EarningsHere's What Key Metrics Tell Us About Teradyne (TER) Q1 Earnings
zacks.com - April 24 at 8:36 PM
Teradyne (NASDAQ:TER) Exceeds Q1 Expectations, Stock SoarsTeradyne (NASDAQ:TER) Exceeds Q1 Expectations, Stock Soars
theglobeandmail.com - April 24 at 7:38 PM
Teradyne (NASDAQ:TER) Releases Q2 2024 Earnings GuidanceTeradyne (NASDAQ:TER) Releases Q2 2024 Earnings Guidance
marketbeat.com - April 24 at 7:16 PM
Teradyne sees strong Q2 results on steady chip-testing equipment demandTeradyne sees strong Q2 results on steady chip-testing equipment demand
finance.yahoo.com - April 24 at 7:12 PM
Teradyne: Q1 Earnings SnapshotTeradyne: Q1 Earnings Snapshot
washingtonpost.com - April 24 at 6:25 PM
Teradyne 1Q Profit Drops Amid Limited Visibility for Improvement Beyond 2QTeradyne 1Q Profit Drops Amid Limited Visibility for Improvement Beyond 2Q
marketwatch.com - April 24 at 5:59 PM
Teradyne Reports First Quarter 2024 ResultsTeradyne Reports First Quarter 2024 Results
accesswire.com - April 24 at 5:19 PM
Heres what Wall Street expects from Teradynes earnings reportHere's what Wall Street expects from Teradyne's earnings report
markets.businessinsider.com - April 23 at 9:57 AM
Earnings To Watch: Teradyne (TER) Reports Q1 Results TomorrowEarnings To Watch: Teradyne (TER) Reports Q1 Results Tomorrow
finance.yahoo.com - April 23 at 8:19 AM
Duality Advisers LP Purchases 27,177 Shares of Teradyne, Inc. (NASDAQ:TER)Duality Advisers LP Purchases 27,177 Shares of Teradyne, Inc. (NASDAQ:TER)
marketbeat.com - April 23 at 7:43 AM
Top high growth investment ratio stocks from each sector - GSTop high growth investment ratio stocks from each sector - GS
msn.com - April 22 at 8:54 PM
Industrial Robot Market CAGR of 44.8%, Uncharted Waters Techniques for Deep Understanding in Observational Research ExploredIndustrial Robot Market CAGR of 44.8%, Uncharted Waters Techniques for Deep Understanding in Observational Research Explored
taiwannews.com.tw - April 22 at 1:58 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Bolt Biotherapeutics logo

Bolt Biotherapeutics

NASDAQ:BOLT
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Canada Zinc Metals

CVE:CZX
Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.
First Capital Realty logo

First Capital Realty

TSE:FCR
Teradyne logo

Teradyne

NASDAQ:TER
Teradyne, Inc. designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications. This segment also provides FLEX test platform systems; J750 test system to address the volume semiconductor devices, including microcontrollers; Magnum platform that tests memory devices, such as flash memory and DRAM; and ETS platform for semiconductor manufacturers, and assembly and test subcontractors in the analog/mixed signal markets. It serves integrated device manufacturers that integrate the fabrication of silicon wafers into their business; fabless companies that outsource the manufacturing of silicon wafers; foundries; and semiconductor assembly and test providers. The System Test segment offers defense/aerospace test instrumentation and systems; storage and system level test systems; and circuit-board test and inspection systems. The Wireless Test segment provides wireless test solutions for silicon validation, wireless module manufacturing, and wireless end device manufacturing under the LitePoint brand. This segment also offers IQxel-MX and IQxel-MW7G series products for edge measurement performance in the manufacturing of connectivity products; IQxstream-5G and IQgig-5G family products to support 4G and 5G technologies; and IQgig-UWB+ for certification and manufacturing test support for ultra wideband products. The Robotics segment provides collaborative robotic arms, autonomous mobile robots, and advanced robotic control software for manufacturing, logistics, and industrial customers. The company was incorporated in 1960 and is headquartered in North Reading, Massachusetts.